Adagene (ADAG)
(Delayed Data from NSDQ)
$2.39 USD
+0.04 (1.70%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $2.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Adagene Inc. Sponsored ADR [ADAG]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
ADG126 Achieved Proof of Concept in MSS CRC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
ADG153, a Novel CD47-Targted Therapy Worth Your Attention; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
All Eyes on ADG126 Readout in MSS CRC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
CTLA-4 Space Continues to Gain Steam; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Encouraging Sneak Peek at ADG126 Combination Therapy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Another Big Pharmas Interest Speaks of SAFEbodys Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Adagene Inc. Sponsored ADR
Industry: Medical - Biomedical and Genetics
A Versatile Player in Cancer Immunotherapy; Initiate With Buy and a $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
|